tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AU:IXC Stock Latest News

Invex Therapeutics Expands Alzheimer’s Research Collaboration and Reports Financial Stability
Company AnnouncementsInvex Therapeutics Expands Alzheimer’s Research Collaboration and Reports Financial Stability
1d ago
IXC
Invex Therapeutics Updates Registered Office Address
PremiumCompany Announcements
Invex Therapeutics Updates Registered Office Address
2M ago
IXC
Invex Therapeutics Reports Reduced Losses but Withholds Dividends
PremiumCompany Announcements
Invex Therapeutics Reports Reduced Losses but Withholds Dividends
2M ago
IXC
Invex Therapeutics Advances Alzheimer’s Research with Promising Exenatide Results
PremiumCompany Announcements
Invex Therapeutics Advances Alzheimer’s Research with Promising Exenatide Results
3M ago
IXC
Invex Therapeutics Secures £114k R&D Tax Rebate from UK Government
PremiumCompany Announcements
Invex Therapeutics Secures £114k R&D Tax Rebate from UK Government
3M ago
IXC
Invex Therapeutics Unveils Promising Alzheimer’s Treatment Results
PremiumCompany AnnouncementsInvex Therapeutics Unveils Promising Alzheimer’s Treatment Results
4M ago
IXC
Invex Therapeutics Announces AGM Results and Future Focus
Premium
Company Announcements
Invex Therapeutics Announces AGM Results and Future Focus
4M ago
IXC
Invex Therapeutics Restructures Amid Clinical Trial Challenges
Premium
Company Announcements
Invex Therapeutics Restructures Amid Clinical Trial Challenges
4M ago
IXC
Invex Therapeutics Seeks Shareholder Approval for New Auditor
PremiumCompany Announcements
Invex Therapeutics Seeks Shareholder Approval for New Auditor
6M ago
IXC
Invex Therapeutics Schedules Virtual AGM
PremiumCompany Announcements
Invex Therapeutics Schedules Virtual AGM
6M ago
IXC
Invex Therapeutics Ltd. Schedules Virtual AGM
PremiumCompany Announcements
Invex Therapeutics Ltd. Schedules Virtual AGM
6M ago
IXC
Invex Therapeutics Advances Neurological Research
PremiumCompany Announcements
Invex Therapeutics Advances Neurological Research
6M ago
IXC
Invex Therapeutics Embraces Corporate Governance Standards
PremiumCompany AnnouncementsInvex Therapeutics Embraces Corporate Governance Standards
8M ago
IXC
Invex Therapeutics Cuts Losses, Skips Dividend
Premium
Company Announcements
Invex Therapeutics Cuts Losses, Skips Dividend
8M ago
IXC
Invex Therapeutics Shareholder Voting Power Shifts
Premium
Company Announcements
Invex Therapeutics Shareholder Voting Power Shifts
8M ago
IXC
Invex Therapeutics Finalizes Key Clinical Trial
PremiumCompany Announcements
Invex Therapeutics Finalizes Key Clinical Trial
9M ago
IXC
Invex Therapeutics Announces Director’s Final Notice
PremiumCompany Announcements
Invex Therapeutics Announces Director’s Final Notice
9M ago
IXC
Invex Therapeutics Options Cease Trading
PremiumCompany Announcements
Invex Therapeutics Options Cease Trading
10M ago
IXC
Invex Therapeutics Bids Farewell to Board Member
PremiumCompany Announcements
Invex Therapeutics Bids Farewell to Board Member
10M ago
IXC
Invex Therapeutics Advances Exenatide Development
PremiumCompany AnnouncementsInvex Therapeutics Advances Exenatide Development
12M ago
IXC
Invex Therapeutics Director Adjusts Holdings
Premium
Company Announcements
Invex Therapeutics Director Adjusts Holdings
1y ago
IXC
Invex Therapeutics Options Expire Unexercised
Premium
Company Announcements
Invex Therapeutics Options Expire Unexercised
1y ago
IXC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >